Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Lichtman

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Cancer Investigation|May 29, 2007
A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabineSamit Hirawat, Jonathan Kolitz, Stuart M Lichtman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2007
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literatureStuart M Lichtman, Hans Wildiers, Etienne Chatelut, et al.
The Lancet. Healthy Longevity|September 13, 2022
Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situationBen Sprangers, Annelien Van der Veen, Marije E Hamaker, et al.
Gynecologic Oncology|December 1, 2009
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatmentRoisin O'Cearbhaill, Qin Zhou, Alexia Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 15, 2013
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancerElizabeth Won, Arti Hurria, Tao Feng, et al.
Gynecologic Oncology|May 19, 2007
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapyEric L Eisenhauer, William P Tew, Douglas A Levine, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 18, 2016
Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular PathogenesisMarcela S Cavalcanti, Anne M Schultheis, Caleb Ho, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Anemia and Functional Disability in Older Adults With CancerCynthia Owusu, Harvey Jay Cohen, Tao Feng, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Cancer Investigation|May 29, 2007
A Phase I dose-finding study using an innovative sequential biweekly schedule of irinotecan followed 24 hours later by capecitabineSamit Hirawat, Jonathan Kolitz, Stuart M Lichtman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2007
International Society of Geriatric Oncology Chemotherapy Taskforce: evaluation of chemotherapy in older patients--an analysis of the medical literatureStuart M Lichtman, Hans Wildiers, Etienne Chatelut, et al.
The Lancet. Healthy Longevity|September 13, 2022
Initiation and termination of dialysis in older patients with advanced cancer: providing guidance in a complicated situationBen Sprangers, Annelien Van der Veen, Marije E Hamaker, et al.
Gynecologic Oncology|December 1, 2009
The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatmentRoisin O'Cearbhaill, Qin Zhou, Alexia Iasonos, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 15, 2013
CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancerElizabeth Won, Arti Hurria, Tao Feng, et al.
Gynecologic Oncology|May 19, 2007
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapyEric L Eisenhauer, William P Tew, Douglas A Levine, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|August 18, 2016
Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular PathogenesisMarcela S Cavalcanti, Anne M Schultheis, Caleb Ho, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 21, 2015
Anemia and Functional Disability in Older Adults With CancerCynthia Owusu, Harvey Jay Cohen, Tao Feng, et al.
Journal of Geriatric Oncology|June 25, 2013
A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomesAmy J Davidoff, Ilene H Zuckerman, Naimish Pandya, et al.
Pageof 13